resTORbio (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- November 30, 2017
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Company Description
- resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
- Market
- Aging-related diseases
- Location
- Boston, MA, USA
- Coinvestors
- Fidelity Management & Research Company, Nest.Bio Ventures, OrbiMed Advisors, Quan Capital, Rock Springs Capital